Open access · OA
via Europe PMC
Targeting of Protein Persulfidation in Aging and Age-Related Disorders.
Pharmaceutics · 2026
Abstract
Aging is associated with a progressive loss of proteostasis(definition) and increased susceptibility to neurodegenerative and metabolic disorders. Among the molecular mechanisms implicated in these processes, protein persulfidation, a hydrogen sulfide (H<sub>2</sub>S)-mediated cysteine modification, has emerged as a critical regulator of protein function and redox homeostasis. Recent studies demonstrate that aging is accompanied by a decline in persulfidation and a concomitant increase in irreversible cysteine hyperoxidation, leading to protein dysfunction and aggregation. Beyond its established role in protecting proteins from oxidative damage, persulfidation has recently been shown to regulate biomolecular condensation and liquid-liquid phase separation, suppressing the formation of pathological protein assemblies linked to aging and neurodegenerative diseases. Moreover, pharmacological approaches that enhance persulfidation, including stimulation of endogenous H<sub>2</sub>S production and treatment with ergothioneine, improve metabolic resilience, increase NAD<sup>+</sup> levels, and promote healthspan(definition) in experimental models. In this review, we discuss emerging evidence linking loss of persulfidation to protein aggregation, biomolecular condensates, and age-related functional decline, and highlight therapeutic strategies aimed at restoring persulfidation as a promising avenue for healthy aging and disease intervention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/pharmaceutics18101266
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
M, H., & J., G. (2026). Targeting of Protein Persulfidation in Aging and Age-Related Disorders. <em>Pharmaceutics</em>. https://doi.org/10.3390/pharmaceutics18101266
Vancouver
M H, J. G. Targeting of Protein Persulfidation in Aging and Age-Related Disorders. Pharmaceutics. 2026. doi:10.3390/pharmaceutics18101266.
BibTeX
@article{hugo2026Target,
title = {Targeting of Protein Persulfidation in Aging and Age-Related Disorders.},
author = {Hugo M and Garcia-Pardo J.},
journal = {Pharmaceutics},
year = {2026},
doi = {10.3390/pharmaceutics18101266},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmaceutics 2026
Open access · CC-BY
Targeting of Protein Persulfidation in Aging and Age-Related Disorders
Pharmaceutics 2026
Open access · OA
Targeting of Protein Persulfidation in Aging and Age-Related Disorders
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
The Role of Protein Persulfidation in Brain Aging and Neurodegeneration
Oxidative Medicine and Cellular Longevity 2016
Open access · CC-BY
Mitochondrial Health in Aging and Age‐Related Metabolic Disease
Frontiers in Physiology 2024
Open access · CC-BY
Mitochondrial dysfunction and its association with age-related disorders
Ageing research reviews 2026
Citation only